Tunay Senturk1,2, Hai Xu1, Krishna Puppala1, Balaji Krishnan1, Scott Sakaguchi1, Lin Y Chen1, Rehan Karim3, Oana Dickinson1, David G Benditt4. 1. Cardiac Arrhythmia and Syncope Center, Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Mail Code 508, 420 Delaware Street SE, Minneapolis, MN, USA. 2. The Department of Cardiology, University of Uludag Medical School, Bursa, Turkey. 3. Division of Cardiology, Department of Medicine, Hennepin County Medical Center, Minneapolis, MN, USA. 4. Cardiac Arrhythmia and Syncope Center, Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Mail Code 508, 420 Delaware Street SE, Minneapolis, MN, USA bendi001@umn.edu.
Abstract
AIMS: It is generally recommended that individuals aspiring to competitive sports should undergo pre-participation cardiovascular assessment, particularly including arrhythmia risk evaluation. In regard to bradyarrhythmias, the 36th Bethesda Conference suggested that asymptomatic cardiac pauses ≤3 s are 'probably of no significance', whereas longer 'symptomatic' pauses may be abnormal. This study focused on assessing the evidence for the '3 s' threshold. METHODS: A systematic literature search was undertaken including Embase (1980-) and Ovid Medline (1950-). The following MeSH terms were used in the database searches: Cardiac.mp & pause.mp. Additionally, pertinent publications found by review of citation lists of identified publications were examined. Individuals with reversible causes of bradyarrhythmia (e.g. drugs) were excluded. RESULTS: The study population comprised 194 individuals with cardiac pauses of 1.35-30 s. In 120 athletes, specific records for pause durations were provided, but it was not always clear whether pauses occurred at rest. Among these 120 athletes, 106 had pauses ≤3 s, of whom 92 were asymptomatic and 14 were symptomatic. Fourteen athletes had pauses >3 s, of whom nine were asymptomatic and five were symptomatic. There were no deaths during follow-up (7.46 ± 5.1 years). With respect to symptoms, the ≤3 s threshold had a low-positive predictive value (35.7%) and low sensitivity (26.3%), but good negative predictive value (86.7%) and specificity (91%). CONCLUSION: While the evidence is not incontrovertible, the 3 s pause threshold does not adequately discriminate between potentially asymptomatic and symptomatic competitive athletes, and alone should not be used to exclude potential competitors. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: It is generally recommended that individuals aspiring to competitive sports should undergo pre-participation cardiovascular assessment, particularly including arrhythmia risk evaluation. In regard to bradyarrhythmias, the 36th Bethesda Conference suggested that asymptomatic cardiac pauses ≤3 s are 'probably of no significance', whereas longer 'symptomatic' pauses may be abnormal. This study focused on assessing the evidence for the '3 s' threshold. METHODS: A systematic literature search was undertaken including Embase (1980-) and Ovid Medline (1950-). The following MeSH terms were used in the database searches: Cardiac.mp & pause.mp. Additionally, pertinent publications found by review of citation lists of identified publications were examined. Individuals with reversible causes of bradyarrhythmia (e.g. drugs) were excluded. RESULTS: The study population comprised 194 individuals with cardiac pauses of 1.35-30 s. In 120 athletes, specific records for pause durations were provided, but it was not always clear whether pauses occurred at rest. Among these 120 athletes, 106 had pauses ≤3 s, of whom 92 were asymptomatic and 14 were symptomatic. Fourteen athletes had pauses >3 s, of whom nine were asymptomatic and five were symptomatic. There were no deaths during follow-up (7.46 ± 5.1 years). With respect to symptoms, the ≤3 s threshold had a low-positive predictive value (35.7%) and low sensitivity (26.3%), but good negative predictive value (86.7%) and specificity (91%). CONCLUSION: While the evidence is not incontrovertible, the 3 s pause threshold does not adequately discriminate between potentially asymptomatic and symptomatic competitive athletes, and alone should not be used to exclude potential competitors. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Douglas P Zipes; Michael J Ackerman; N A Mark Estes; Augustus O Grant; Robert J Myerburg; George Van Hare Journal: J Am Coll Cardiol Date: 2005-04-19 Impact factor: 24.094
Authors: Araceli Boraita; María-Eugenia Heras; Pedro L Valenzuela; Leonel Diaz-Gonzalez; Francisco Morales-Acuna; María Alcocer-Ayuga; Sonia Bartolomé-Mateos; Alejandro Santos-Lozano; Alejandro Lucia Journal: Front Cardiovasc Med Date: 2022-07-22
Authors: Robert Gajda; Beat Knechtle; Anita Gębska-Kuczerowska; Jacek Gajda; Sebastian Stec; Michalina Krych; Magdalena Kwaśniewska; Wojciech Drygas Journal: Int J Environ Res Public Health Date: 2022-08-19 Impact factor: 4.614